XML 25 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Assets:    
Cash and cash equivalents $ 9,408 $ 7,854
Investments 3,117 3,000
Accounts receivable, net 24,431 21,742
Inventories 17,760 18,496
Other current assets 5,292 5,277
Total current assets 60,008 56,369
Long-term investments 23,025 20,812
Property and equipment, net 12,896 12,606
Operating lease right-of-use assets 19,122 20,729
Goodwill 79,121 79,552
Intangible assets, net 29,026 31,142
Separate accounts assets 5,087 4,881
Other assets 4,714 4,624
Total assets 232,999 230,715
Liabilities:    
Accounts payable 12,544 11,138
Pharmacy claims and discounts payable 17,330 15,795
Health care costs payable 8,808 7,936
Policyholders’ funds 4,301 4,270
Accrued expenses 17,670 14,243
Other insurance liabilities 1,303 1,557
Current portion of operating lease liabilities 1,646 1,638
Current portion of long-term debt 4,205 5,440
Total current liabilities 67,807 62,017
Long-term operating lease liabilities 18,177 18,757
Long-term debt 51,971 59,207
Deferred income taxes 6,270 6,794
Separate accounts liabilities 5,087 4,881
Other long-term insurance liabilities 6,402 7,007
Other long-term liabilities 1,904 2,351
Total liabilities 157,618 161,014
Commitments and contingencies (Note 16)
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus 47,377 46,513
Treasury stock, at cost: 422 and 423 shares at December 31, 2021 and 2020 (28,173) (28,178)
Retained earnings 54,906 49,640
Accumulated other comprehensive income 965 1,414
Total CVS Health shareholders’ equity 75,075 69,389
Noncontrolling interests 306 312
Total shareholders’ equity 75,381 69,701
Total liabilities and shareholders’ equity $ 232,999 $ 230,715